baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ACS,ACT.CO.SER.INH.EO-,50/ ES0167050915 /

2024-09-18 8:12:33 AM	Chg. +0.520	Volume	Bid8:59:59 PM	Ask8:59:59 PM	Market Capitalization	Dividend Y.	P/E Ratio
41.660EUR	+1.26%	0 Turnover: 0.000	-Bid Size: -	-Ask Size: -	10.88 bill.EUR	4.70%	13.91

Newsfile Corp 09-06 Air & Energy of NWFL Introduces Comprehensive Energy Efficiency Audits, Enhancing Pensacola Air Cond...

GlobeNewswire 08-29 ACGME Names Mary E. Klingensmith, MD Next Chief Accreditation Officer

GlobeNewswire 08-27 Parsons Selected as Lead Engineer to Add Express Toll Lanes to State Route 400 in Georgia

GlobeNewswire 08-26 Stop & Shop Announces Plans to Stop Selling Tobacco Products

GlobeNewswire 08-22 Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Me...

GlobeNewswire 08-22 Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacim...

GlobeNewswire 08-21 ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing

GlobeNewswire 08-21 Rose Hill Announces Addition of Two Senior Advisors to Advisory Team

GlobeNewswire 08-19 Auron Presents Preclinical Data at American Chemical Society Annual Meeting

Newsfile Corp 08-15 Droplet Lab Launches Innovative Instrument Set to Elevate Chemistry and Material Science Education

GlobeNewswire 08-15 NobleAI to Present at American Chemical Society’s Fall Conference, “Elevating Chemistry”

GlobeNewswire 08-06 Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug

GlobeNewswire 08-06 SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article...

GlobeNewswire 08-02 FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and...

GlobeNewswire 07-30 Award-Winning Material Inventor Joins as Advisor for AI Innovator of Climate Technologies

GlobeNewswire 07-30 NewHydrogen CEO Steve Hill Explores AI’s Role in Cutting-Edge Hydrogen Solutions with Renowned Compu...

TeleTrader 07-17 Samsung to launch AI-powered ACs in N. America

GlobeNewswire 07-03 NH TherAguix Announces Publication of Groundbreaking Study on AGuIX® Nanoparticles Enhancing Cervica...

GlobeNewswire 07-03 Advantest to Showcase Latest Test Technology at SEMICON West 2024, July 9-11, in San Francisco

GlobeNewswire 07-02 Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroend...

GlobeNewswire 06-25 Sustainable Mom and Baby Brands Commit to Tackling Global Plastic Pollution with rePurpose Global

GlobeNewswire 06-21 Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in...

GlobeNewswire 06-17 ACS Journal Validates HydroGraph Cement Performance

GlobeNewswire 06-12 Intelligent Product Solutions Launches Advanced Concept Studio (ACS) Division Focused on Industrial ...

GlobeNewswire 06-10 Noodles & Company Appoints Britain Peakes to its Board of Directors

ACS,ACT.CO.SER.INH.EO-,50/ ES0167050915 /

If you wish to receive reply to your feedback, please provide your email address.